Scholar Rock Sees Phase III Path For SMA Drug

Apitegromab Being Studied As Monotherapy And In Combination

 
• By Alaric DeArment
  
3D spinal cord
Scholar Rock announced 12-month results from its Phase II TOPAZ study of apitegromab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip